ArticleDrug delivery and translational research2026

Targeted delivery of IFN-α-anti-GPC3 fusion protein via mRNA-LNP platform elicits potent anti-tumor immunity in hepatocellular carcinoma.

Yajie Pan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.